Never was this truer – if you have money, you can buy anything in India!
Roche India and Cipla have announced a wonder drug for mild to moderate COVID cases. This is a cocktail of antibodies that can prevent a patient’s condition from getting worse, ca prevent fatality and even cut the duration of illness by 4 days. This is aimed at patients who are at high risk of developing complications, but do not require Oxygen support. With this cocktail, such patients can be treated in the comfort of their homes and their mild to moderate symptoms are likely to stay that way – mild to moderate!
The first batch of this cocktail – Casirivimab and Imdevimab – is now available in India. You can buy this drug through hospitals and COVID care centers. The second batch will be available in mid-June. The cost of one package is Rs 1,19,500/- but one pack can treat two patients, so the cost per patient will be Rs 59,750/-
This cocktail might prove to be a game changer in our fight against COVID, but the cost may be prohibitive for many people across the country.